Total Funding
18
Total FundingDebt Financing raised
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Dualogics provides the latest advancements in protein engineering to create a new class of protein based therapies.
- Dennis McNamara: Chief Business Officer
- Ryan Hallett: Chief Executive Officer, Co-founder
About the Company
Dualogics is a biotechnology company housed at the University of North Carolina at Chapel Hill. Dualogics uses a proprietary bispecific antibody technology to create bispecific antibody products with superior properties compared to alternative methods. Our goal is to collaborate with academic and industrial partners to develop and test a suite of
multifunctional therapies and reagents.
